The Euro-Phospholipid project: Epidemiology of the antiphospholipid syndrome in Europe

Lupus

Volumn 18, Issue 10, 2009, Pages 889-893

  Cervera, Ricard ^a   Boffa, M C ^b   Khamashta, M A ^c   Hughes, G R V ^d  

^a HOSPITAL CLÍNIC   (Spain)

^b HÔPITAL JEAN VERDIER   (France)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d LONDON BRIDGE HOSPITAL   (United Kingdom)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Lupus anticoagulant

Indexed keywords

CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ABDOMINAL DISEASE; ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CHOREA; CLINICAL FEATURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EAR NOSE THROAT DISEASE; ECLAMPSIA; EPILEPSY; EUROPE; EYE DISEASE; FEMALE; FETUS WASTAGE; HEART INFARCTION; HEMATOLOGIC DISEASE; HUMAN; INFANT; LEG THROMBOSIS; LEUKOPENIA; LIVEDO RETICULARIS; LUNG EMBOLISM; LUPUS LIKE SYNDROME; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; ONSET AGE; OSTEOARTHRITIS; PREECLAMPSIA; PREMATURITY; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN DISEASE; SOLUTIO PLACENTAE; SUPERFICIAL THROMBOPHLEBITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TRANSIENT ISCHEMIC ATTACK;

ANTIPHOSPHOLIPID SYNDROME; COHORT STUDIES; EUROPE; FOLLOW-UP STUDIES; HUMANS; MORBIDITY; PROSPECTIVE STUDIES;

EID: 68949175636     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203309106832     Document Type: Article

References (11)

1. Bertolaccini ML Khamashta MA Hughes GRV. Diagnosis of antiphospholipid syndrome. Nat Clin Pract Rheumatol 2005; 1: 40-46.
2. Asherson RA Khamashta MA Ordi-Ros J et al. The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374.
3. Bucciarelli S Espinosa G Cervera R. Mortality in the catastrophic antiphospholipid syndrome. Causes of death and prognostic factors in a series of 250 patients. Arthritis Rheum 2006; 54: 2568-2576.
4. Wilson WA Gharavi AE Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
5. Cervera R Piette JC Font J et al. Antiphospholipid syndrome. Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027.
6. Miyakis S Lockshin MD Atsumi T et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
7. Khamashta MA Cuadrado MJ Mujic F Taub NA Hunt BJ Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-997.
8. Muñoz-Rodríguez FJ Font J Cervera R et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 1999; 29: 182-190.
9. Balasch J Carmona F López-Soto A et al. Low-dose aspirin for prevention of pregnancy losses in women with primary antiphospholipid syndrome. Hum Reprod 1993; 8: 2234-2239.
10. Derksen RHWM. de Groot, PhG, Nieuwenhuis, HK, Christiaens, GCML. How to treat women with antiphospholipid antibodies in pregnancy. Ann Rheum Dis 2001; 60: 1-3.
11. Cervera R; Khamashta MA; Shoenfeld Y; et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: A multicenter prospective study of 1,000 patients. Ann Rheum Dis 2008 Sep 18. [Epub ahead of print].